Skip to Main Content

Paper Details

The Impact of Litigation-Associated Reports on Signal Identification in the US FDA's Adverse Event Reporting System.
Drug Saf
3
2019
Author NameAffiliation
Gerald J Dal PanCenter for Drug Evaluation and Research
  • 1 - 1

Datasets

Release 1.2